Advanced Medical Solutions Group (LSE:AMS) PB Ratio: 2.33 (As of Jun. 26, 2026) — 18% Below Median


LSE:AMS Advanced Medical Solutions Group PLC LSE:AMS
89 GF Score
Price £2.79
GF Value £3.69
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Advanced Medical Solutions Group PB Ratio?

Advanced Medical Solutions Group LSE:AMS +16.04% 89 PB Ratio is 2.33 as of Jun. 26, 2026, which is 18% below its 10-year median of 2.85. GuruFocus rates LSE:AMS with a GF Score™ of 89/100 and a GF Value™ of £3.69 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Advanced Medical Solutions Group ranks worse than 54.57% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Advanced Medical Solutions Group's share price is £2.785. Advanced Medical Solutions Group's Book Value per Share for the quarter that ended in Dec. 2025 was £1.20. Hence, Advanced Medical Solutions Group's PB Ratio of today is 2.33.

Warning Sign:

Advanced Medical Solutions Group PLC stock PB Ratio (=2.01) is close to 2-year high of 2.22.

The historical rank and industry rank for Advanced Medical Solutions Group's PB Ratio or its related term are showing as below:

LSE:AMS' s PB Ratio Range Over the Past 10 Years
Min: 1.57   Med: 2.85   Max: 5.87
Current: 2.33

During the past 13 years, Advanced Medical Solutions Group's highest PB Ratio was 5.87. The lowest was 1.57. And the median was 2.85.

LSE:AMS's PB Ratio is ranked worse than
54.57% of 788 companies
in the Medical Devices & Instruments industry
Industry Median: 2.02 vs LSE:AMS: 2.33

During the past 12 months, Advanced Medical Solutions Group's average Book Value Per Share Growth Rate was 6.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 3.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 4.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 8.60% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Advanced Medical Solutions Group was 36.70% per year. The lowest was -16.80% per year. And the median was 9.40% per year.

Back to Basics: PB Ratio


Advanced Medical Solutions Group  (LSE:AMS) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Advanced Medical Solutions Group PB Ratio Related Terms


Advanced Medical Solutions Group PB Ratio Historical Data

* Premium members only.

The historical data trend for Advanced Medical Solutions Group's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Medical Solutions Group PB Ratio Chart

Advanced Medical Solutions Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.43 2.37 1.82 1.76 1.82

Advanced Medical Solutions Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.82 1.89 1.76 1.83 1.82

LSE:AMS vs ISRG, BDX, MDLN: PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's PB Ratio falls into.


LSE:AMS
89GF Score
Advanced Medical Solutions Group PLC LSE:AMS
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Medical Solutions Group PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Advanced Medical Solutions Group's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=2.785/1.196
=2.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 2.33 mean?
Advanced Medical Solutions Group (LSE:AMS) has a PB Ratio of 2.33 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Advanced Medical Solutions Group and its competitors. This is 18% below median its historical median of 2.85. Over the past decade, Advanced Medical Solutions Group's PB Ratio has ranged from 1.57 to 5.87. According to the industry distribution chart, Advanced Medical Solutions Group ranks #430 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 54.6%.
Is Advanced Medical Solutions Group's PB Ratio too high?
Advanced Medical Solutions Group's current PB Ratio of 2.33 is 18% below median its 10-year median of 2.85. Over the past 10 years, this metric has ranged from a low of 1.57 to a high of 5.87. The Medical Devices & Instruments industry median PB Ratio is 2.02. Advanced Medical Solutions Group's value of 2.33 is 15.3% above this industry median. Based on the distribution chart, Advanced Medical Solutions Group ranks #430 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Advanced Medical Solutions Group has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Advanced Medical Solutions Group ranks #430 out of 788 companies for PB Ratio. This places Advanced Medical Solutions Group in the lower half of its industry. The industry median PB Ratio is 2.02. Advanced Medical Solutions Group's value of 2.33 is 15.3% above this benchmark. Historically, Advanced Medical Solutions Group's own PB Ratio has ranged from 1.57 to 5.87 over the past decade. While the company's 10-year median is 2.85 vs. the industry median of 2.02, Advanced Medical Solutions Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Medical Solutions Group's current PB Ratio of 2.33 is 15.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Advanced Medical Solutions Group and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Medical Solutions Group's current PB Ratio is 2.33, which is 18% below median its own 10-year median of 2.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (LSE:AMS) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.69, compared to a current price of £2.79 — trading 24.5% below its estimated fair value. The current PB Ratio is 2.33, which is 18% below median its 10-year median of 2.85 and 15.3% above the Medical Devices & Instruments industry median of 2.02. Advanced Medical Solutions Group's overall GF Score™ is 89/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Advanced Medical Solutions Group (LSE:AMS), the current PB Ratio is 2.33 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Medical Solutions Group (LSE:AMS) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued. The current stock price of £2.79 is trading 24.5% below its estimated GF Value™ of £3.69. GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.

Key valuation signals for LSE:AMS:

  • PB Ratio: 2.33 (18% below median its 10-year median of 2.85)
  • GF Value™: £3.69 vs. price of £2.79 (24.5% below fair value)
  • GF Score™: 89/100 with 6 warning signs
  • Industry Position: 15.3% above the Medical Devices & Instruments median (#430 of 788)

No single metric tells the full story. See the LSE:AMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advanced Medical Solutions Group Business Description

Other Exchanges AMSl:UKAQA:Germany
Address Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
89GF Score

Get the complete analysis for LSE:AMS

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.79
Price
£3.69
GF Value